MapLight Therapeutics (MPLT) PT Raised to $45 at Needham
Tweet Send to a Friend
(Updated - July 10, 2026 7:05 AM EDT)
Needham analyst Ami Fadia raised the price target on MapLight Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst Ami Fadia raised the price target on MapLight Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


